PMID- 20399802 OWN - NLM STAT- MEDLINE DCOM- 20100818 LR - 20211028 IS - 1872-6216 (Electronic) IS - 0047-6374 (Print) IS - 0047-6374 (Linking) VI - 131 IP - 5 DP - 2010 May TI - Endogenous oxidative stress prevents telomerase-dependent immortalization of human endothelial cells. PG - 354-63 LID - 10.1016/j.mad.2010.04.004 [doi] AB - INTRODUCTION: With aging, oxidative stress accelerates vascular endothelial cell (EC) telomere shortening-induced senescence, and may promote atherosclerosis in humans. Our aim was to investigate whether an antioxidant treatment combined with telomerase (hTERT) over-expression would prevent senescence of EC isolated from patients with severe atherosclerosis. METHODS: Cells were isolated from internal mammary arteries (n=11 donors), cultured until senescence with or without N-acetylcystein (NAC) and infected, or not, with a lentivirus over-expressing hTERT. RESULTS: Compared to control EC, hTERT-NAC cells had increased telomerase activity, longer telomeres and underwent more cell divisions. According to the donor, hTERT-NAC either delayed (n=5) or prevented (n=4) EC senescence, the latter leading to cell immortalization. Lack of cell immortalization by hTERT-NAC was accompanied by an absence of beneficial effect of NAC alone in paired EC. Accordingly, lack of EC immortalization by hTERT-NAC was associated with high endogenous susceptibility to oxidation. In EC where hTERT-NAC did not immortalize EC, p53, p21 and p16 expression increased with senescence, while oxidative-dependent DNA damage associated with senescence was not prevented. CONCLUSION: Our data suggest that irreversible oxidative stress-dependent damages associated with cardiovascular risk factors are responsible for senescence of EC from atherosclerotic patients. CI - Copyright 2010 Elsevier Ireland Ltd. All rights reserved. FAU - Voghel, Guillaume AU - Voghel G AD - Department of Surgery, Research Center, Montreal Heart Institute, Universite de Montreal, Montreal, Quebec, Canada. FAU - Thorin-Trescases, Nathalie AU - Thorin-Trescases N FAU - Mamarbachi, Aida M AU - Mamarbachi AM FAU - Villeneuve, Louis AU - Villeneuve L FAU - Mallette, Frederick A AU - Mallette FA FAU - Ferbeyre, Gerardo AU - Ferbeyre G FAU - Farhat, Nada AU - Farhat N FAU - Perrault, Louis P AU - Perrault LP FAU - Carrier, Michel AU - Carrier M FAU - Thorin, Eric AU - Thorin E LA - eng GR - 14496-4/CAPMC/CIHR/Canada PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20100424 PL - Ireland TA - Mech Ageing Dev JT - Mechanisms of ageing and development JID - 0347227 RN - 0 (Cyclin-Dependent Kinase Inhibitor p16) RN - 0 (Cyclin-Dependent Kinase Inhibitor p21) RN - 0 (Free Radical Scavengers) RN - 0 (Tumor Suppressor Protein p53) RN - EC 2.7.7.49 (Telomerase) RN - WYQ7N0BPYC (Acetylcysteine) SB - IM EIN - Mech Ageing Dev. 2010 Sep;131(9):599 MH - Acetylcysteine/pharmacology MH - Aged MH - Atherosclerosis/enzymology/*physiopathology MH - Cells, Cultured MH - *Cellular Senescence MH - Cyclin-Dependent Kinase Inhibitor p16/metabolism MH - Cyclin-Dependent Kinase Inhibitor p21/metabolism MH - DNA Damage MH - Endothelial Cells/drug effects/*enzymology MH - Female MH - Free Radical Scavengers/pharmacology MH - Humans MH - Male MH - Middle Aged MH - *Oxidative Stress MH - Risk MH - Telomerase/*metabolism MH - Tumor Suppressor Protein p53/metabolism PMC - PMC3700881 MID - CAMS3017 OID - NLM: CAMS3017 COIS- Conflict of interest None declared. EDAT- 2010/04/20 06:00 MHDA- 2010/08/19 06:00 PMCR- 2013/07/03 CRDT- 2010/04/20 06:00 PHST- 2010/01/04 00:00 [received] PHST- 2010/02/26 00:00 [revised] PHST- 2010/04/09 00:00 [accepted] PHST- 2010/04/20 06:00 [entrez] PHST- 2010/04/20 06:00 [pubmed] PHST- 2010/08/19 06:00 [medline] PHST- 2013/07/03 00:00 [pmc-release] AID - S0047-6374(10)00075-8 [pii] AID - 10.1016/j.mad.2010.04.004 [doi] PST - ppublish SO - Mech Ageing Dev. 2010 May;131(5):354-63. doi: 10.1016/j.mad.2010.04.004. Epub 2010 Apr 24.